Cell surface receptors: A short course on theory and methods: Third edition

Cell Surface Receptors: A Short Course on Theory and Methods: Third Edition

Volumn , Issue , 2005, Pages 1-219

  Limbird, Lee E ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900698631     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007-0-387-23080-7     Document Type: Book

References (289)

1. Albert, A. (1979) Chemotherapy: History and principles. In Selective Toxicity (6th ed.), Chapman and Hall (eds.). New York: John Wiley and Sons, pp. 182-199. (This section of chapter 6 summarized P. Erhlich's fundamental contributions to chemotherapy and general "receptor" principles.)
2. Albert, P. R. and Robillard, L. (2002) G protein specificity: traffic direction required. Cell Signal. 14(5):407-418.
3. Ariens, EJ. (1954) Affmity and intrinsic activity in the theory of competitive inhibition. Part I. Problems and theory. Arch. Int. Pharmacodyn. 99:32-49.
4. Ariens, E. J. (1960) Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn. 127:459-478.
5. Ariens, E. J. and De Groot, W. M. (1954) Affinity and intrinsic-activity in the theory of competitive inhibition. III. Homologous decamethonium- derivatives and succinylcholineesters. Arch. Int. Pharmacodyn. 99:193-205.
6. Barger, G. and Dale, H. H. (1910) Chemical structure and sympathomimetic action of amines. J. Physiol. 41:19-59.
7. Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C, Leff, P. and Clarke, W. P. (1998) Effector Pathway-Dependent Relative Effficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus. Mol. Pharm. 54:94-104.
8. Bernard, C. (1856) Physiological analysis of the properties of the muscular and nervous system by means of curare. Comptes Rendus Acad. de Sci. 43:825-829.
9. Translated and reprinted in Readings in Pharmacology, L. Shuster (ed.). Boston: Little, Brown and Company, pp. 73-81.
10. Birdsall, N. J., Lazareno, S. and Matsui, H. (1996) Allosteric regulation of muscarinic receptors. Prog. Brain Res. 109:147-151.
11. Black, J. W. and Leff, P. (1983) Operational models of pharmacological agonism. Proc. Royal Soc. LondonB. 220:141-162.
12. Black, J. W., Leff, P. and Shankley, N. P., with an appendix by J. Wood (1985) An operational model of pharmacological agonism: The effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharm. 84:561-571.
13. Black, J. W. and Shankley, N. P. (1990) Interpretation of agonist affinity estimations: The question of distributed receptor states. Proc. Royal Soc. London B. 240:503-518.
14. Changeux, J.-P. and Podleski, T. R. (1968) On the excitability and cooperativity of the electroplax membrane. Proc. Natl. Acad. Sci. USA 59:944-950.
15. Christopoulos, A. and Kenakin, T. P. (2002) G Protein-Coupled Receptor Allosterism and Complexing. Pharm. Rev. 54:323-374.
16. Clark, A. J. (1926a) The reaction between acetyl choline and muscle cells. J. Physiol. 61:530-546.
17. Clark, A. J. (1926b) The antagonism of acetyl choline by atropine. J. Physiol. 61:547-556.
18. Clark, A. J. (1927) The reaction between acetyl choline and muscle cells. Part II. J. Physiol. 64:123-143.
19. Clark, A. J. (1937) General Pharmacology. Berlin: Verlag von Julius Springer, pp. 61-98, 176-206 and 215-217.
20. Clark, AJ. and Raventos, J. (1937) The antagonism of acetylcholine and of quaternary ammonium salts. Quant. J. Exp. Physiol. 26:275-392.
21. Colquhoun, D. (1973) The relation between classical and cooperative models for drug action. In Drug Receptors, H. P. Rang (ed.). Baltimore: University Park, pp. 149-182.
22. Dale, H. H. (1914) The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharm. Exp. Ther. 6:174-190.
23. Erhlich, P. (1913) Chemotherapeutics: Scientific principles, methods and results. Lancet 2:445-451.
24. Furchgott, R. F. (1955) The pharmacology of vascular smooth muscle. Pharm. Rev. 7:183-235.
25. Furchgott, R. F. (1964) Receptor mechanisms. Ann. Rev. Pharmacology 4:21-50.
26. Furchgott, R. F. and Bhadrakom, S. (1953) Reactions of strips of rabbit aorta to epinephrine, isoproterenol, sodium nitrite and other drugs. J. Pharm. Exp. Ther. 108:129-143.
27. Gaddum, J. H. (1926) The action of adrenalin and ergotamine on the uterus of the rabbit. J. Physiol. 61:141-150.
28. Gaddum, J. H. (1937) The quantitative effects of antagonistic drugs. J. Physiol. 89:7P-9P.
29. Gaddum, J. H. (1957) Theories of drug antagonism. Pharm. Rev. 9:211-217.
30. Gether, U. and Kobilka, B. K. (1998) G Protein-coupled Receptors. II. Mechanism of Agonist Activation. J. Biol. Chem. 273(29):17979-17982.
31. 2 Adrenergic Receptor. J. Biol. Chem. 276(27):24433-24436.
32. Gilchrist, A., Li, A. and Hamm, H. E. (2002) Design and use of C-terminal minigene vectors for studying role of heterotrimeric G proteins. Methods Enzymol. 344:58-69.
33. Goldstein, A., Aronow, L. and Kalman, S. M. (1974) Principles of Drug Action: The Basis of Pharmacology (2nd ed.). New York: John Wiley and Sons, pp. 82-111.
34. Hall, D. A. (2000) Modeling the Functional Effects of Allosteric Modulators at Pharmacological Receptors: An Extension of the Two-State Model of Receptor Activation. Mol. Pharm. 58:1412-1423.
35. Karlin, A. (1967) On the application of a "plausible model" of allosteric proteins to the receptor of acetylcholine. J. Theoret. Biol. 16:306-320.
36. Kenakin, T. (1995) Agonist-receptor efficacy II: agonist trafficking of receptor signals. TiPS 16:232-238.
37. Kenakin, T. (2004) Principles: Receptor Theory in Pharmacology. Trends Pharm. Sci. 25:186-192.
38. Kobilka, B. (2004) Agonist binding: a multi-step process. Mol. Pharm. 65:1060-1062.
39. Langley, J. N. (1878) On the physiology of the salivary secretion. Part II. On the mutual antagonism of atropin and pilocarpin, having especial reference to their relations in the submaxillary gland of the cat. J. Physiol. 1:339-369.
40. Langley, J. N. (1909) On the contraction of muscle, chiefly in relation to the presence of "receptive" substances. Part IV. The effect of curare and of some other substances on the nicotine response of the sartorius and gastrocnemius muscles of the frog. J. Physiol. 39:235-295.
41. Leff, P., Scaramellini, C., Law, C. and McKechnie, K. (1997) A three-state receptor model of agonist action. TiPS 18(10):355-362.
42. 2 adrenergic receptor. Mol. Pharm. 65:1181-1190.
43. Lohse, M. J., Benovic, J. L., Caron, M. G. and Lefkowitz, R. J. (1990) Multiple pathways of rapid β2-adrenergic receptor desensitization: Delineation with specific inhibitors. J. Biol. Chem. 265(6):3202-3211, especially appendix pp. 3210-3211.
44. Monod, J., Wyman, J. and Changeux, J.-P. (1965) On the nature of allosteric transitions: A plausible model. J. Mol. Biol. 12:88-118.
45. Neubig, R. R., Spedding, M., Kenakin, T. and Christopoulos, A. (2003) Update on Terms and Symbols in Quantitative Pharmacology. NC-IUPHAR XXXV III 55:597-606.
46. Nickerson, M. (1956) Receptor occupancy and tissue response. Nature 78:697-698.
47. Paton, W. D. M. (1961) A theory of drug action based on the rate of drug-receptor combination. Proc. Royal Soc. London B. 154:21-69.
48. Perez, D. M., Hwa, J., Gaivin, R., Mathur, M., Brown, F. and Graham, R. M. (1996) Constitutive activation of a single effector pathway: evidence for multiple activation sites of a G protein-coupled receptor. Mol. Pharmacol. 49:112-122.
49. Stephenson, R. P. (1956) A modification of receptor theory. Br. J. Pharm. 11:379-393.
50. Seifert, R. and Wenzel-Seifert, K. (2002) Constitutive activity of G protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366(5):381-416.
51. Seifert, R., Wenzel-Seifert, K., Gether, U. and Kobilka, B. K. (2001) Functional Differences between full and Partial Agonists: Evidence for Ligand-Specific Receptor Conformations. J. Pharm. & Exp. Ther. 297:1218-1226.
52. Spengler, D., Waeber, C, Pantaloni, C, Holsboer, F., Bockaert, J., Seeberg, P. H. and Journot, L. (1993) Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175.
53. Stokes, G. G. (1864) On the Reduction and Oxidation of the Colouring Matter of the Blood. Proc. Roy. Soc. London 13:355-364.
54. 2A- adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc. Natl. Acad. Sci. USA 99(19):12471-12476.
55. Thron, C. D. and Waud, D. R. (1968) The rate of action of atropine. J. Pharm. Exp. Ther. 160:91-105.
56. Van Rossum, J. M. and Ariens, E. J. (1962) Receptor reserve and threshold phenomena. II. Theories on drug-action and a quantitative approach to spare receptors and threshold values. Arch. Int. Pharmacodyn. 136:385-413.
57. Whaley, B. S., Yuan, N., Birnbaumer, L., Clark, R. B. and Barber, R. (1994) Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol. Pharmacol. 45(3):481-489.
58. Ahlquist, R. P. (1948) A study of the adrenotropic receptors. Am. J. Physiol. 155:586-600.
59. Arunlakshana, O. and Schild, H. O. (1959) Some quantitative uses of drug antagonists. Brit. J. Pharm. 14:48-58.
60. Barlow, R., Scott, N. C. and Stephenson, R. P. (1967) Brit. J. Pharmacol. 31:188-196.
61. Colquhoun, D. (1973) The relation between classical and cooperative models for drug action. In Drug Receptors, H. P. Rang (ed.), pp. 149-182. Baltimore: University Park Press.
62. Black, J. W., Gershkowitz, V. P., Leff, P. and Shankley, N. P. (1986) Analysis of competitive antagonism when this property occurs as part of a pharmacological resultant. Brit. J. Pharm. 89:547-555.
63. De Lean, A., Stadel, J. M. and Lefkowitz, R. J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:7108-7117.
64. Furchgott, R. F. (1972) The classification of adrenoceptors (adrenergic receptors): An evaluation from the standpoint of receptor theory. In Handbuch der Experimentellen Pharmakologie, vol. 33, Catecholamines, H. Blashko and E. Muscholl (eds.), pp. 283-335. Berlin: Springer-Verlag.
65. Furchgott, R. F. (1978) Pharmacological characterization of receptors: Its relation to radioligand-binding studies. Fed. Proc. 37:115-120.
66. Gaddum, J. H. (1937) The quantitative effects of antagonist drugs. J. Physiol. (London) 89:79-9P.
67. Gaddum, J. H. (1943) Biological aspects: The antagonism of drugs. Trans. Faraday Soc. 39:323-333.
68. Gaddum, J. H. (1957) Theories of drug antagonism. Pharm. Rev. 9:211-217.
69. Kenakin, T. P. (1984a) The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 36:165-222.
70. Kenakin, T. P. (1987a) The Pharmacological Analysis of Drug Receptor Interaction. NY: Raven Press.
71. Kenakin, T. P. (1987b) What can we learn from models of complex drug antagonism in classifying hormone receptors? In Perspectives on Receptor Classification, Receptor Biochemistry and Methodology, vol. 6, pp. 167-185.
72. Black, J. W., Jenkinson, D. H. and Gershkowitz, V. P. (eds.). NY: Alan R. Liss. Kenakin, T. P. (2001) Quantitation in Receptor Pharmacology. Rec. & Chan. 7:371-385.
73. Kenakin, T. P. (2004) A Pharmacology Primer: Theory, Methods, and Application. San Diego: Elsevier Press, Inc.
74. MacKay, D. (1966) A general analysis of the receptor-drug interaction. Brit. J. Pharmacol. 26:9-16.
75. 2 and affmity constants for pharmacological competitive antagonists be evaluated? J. Pharm. Pharmac. 30:312-313.
76. MacKay, D. (1982) Dose-response curves and mechanisms of drug action. Trends in Pharm. Sci. 2:496-499.
77. Parker, R. B. and Waud, D. R. (1971) Pharmacological estimation of drug-receptor dissociation constants: Statistical evaluation. I. Agonists. J. Pharm. Exp. Ther. 177:1-12.
78. Schild, H. O. (1947) pA, a new scale for the measurement of drug antagonism. Brit. J. Pharm. 2:189-206.
79. Schild, H. O. (1957) Drug antagonism and pAx. Pharm. Rev. 9:242-245.
80. Schild, H. O. (1973) Receptor classification with special reference to β-adrenergic receptors. In Drug Receptors, pp. 29-36, H. P. Rang (ed.). Baltimore: University Park Press.
81. Stephenson, R. P. (1956) A modification of receptor theory. Brit. J. Pharm. 11:379-393.
82. Thron, C. D. (1973) On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol. Pharmacol 9:1-9.
83. Van Rossum, J. M. (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143:299-330.
84. Waud, D. R. (1969) On the measurement of the affinity of partial agonists for receptors. J. Pharm. Exp. Ther. 170:117-122.
85. Berg K. A., Maayani, S., Goldfarb, J., Scaramellini, C, Leff, P. and Clarke, W. P. (1998) Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus. Mol. Pharm. 54:94-104.
86. Berthelson, S. and Pettinger, W. A. (1977) A functional basis for classification of a-adrenergic receptors. Life Sci. 21:595-606.
87. Del Castillo, J. and Katz, B. (1957) Interaction at endplate receptors between different choline derivatives. Proc. Royal Soc. Lond., Series B, 146:369-381.
88. Furchgott, R. F. (1954) Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J. Pharm. Exp. Ther. 111:265-284.
89. Furchgott, R. F. (1966) The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. In Advances in Drug Research, vol. 3, pp. 21-55. Harper, N. J. and Simmonds, A. B. (eds.). New York: Academic Press.
90. Furchgott, R. F. and Bursztyn, P. (1967) Comparison of dissociation constants and relative efficacies of selective agonists acting on parasympathetic receptors. Ann. NY Acad. Sci. 139:882-889.
91. Kaumann, A. J. and Marano, M. (1982) On equilibrium dissociation constants for complexes of drug receptor subtypes: selective and nonselective interactions of partial agonists with two β-adrenoceptor subtypes mediating positive chronotropic effects of (-) isoprenaline in kitten atria. Naunyn Schmiedebergs Arch. Pharmacol. 219:216-221.
92. Kenakin, T. P. (1984b) The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br. J. Pharmacol. 81(1):131-141.
93. Kenakin, T. P. and Boselli, C. (1989) Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea. J. Pharmacol. Exp. Ther. 250(3):944-952.
94. Kono, T. and Barham, F. W. (1971) The relationship between the insulin-binding capacity of fat cells and the cellular response to insulin. J. Biol. Chem. 246:6210-6216.
95. Kuwasako, K., Cao Y-N, Nagoshi, Y., Tsuruda, T., Kitamura, K. and Eto, T. (2004) Characterization of the Human Calcitonin Gene-Related Peptide Receptor Subtypes Associated with Receptor Activity-Modifying Proteins. Mol. Pharm. 65:207-213.
96. Langer, S. Z. and Trendelenberg, U. (1960) The effect of a saturable uptake mechanism on the slope of dose-response curves for sympathomimetic amines and on the shifts of doseresponse curves produced by a competitive antagonist. J. Pharm. Exp. Ther. 167:117-142.
97. Leff, P., Dougall, I. G., Harper, D. H. and Dainty, I. A. (1990) Errors in agonist affinity estimation: Do they and should they occur in isolated tissue experiments? Trends in Pharm. Sci. 11:64-67.
98. Lefkowitz, R. J., Cotecchia, S., Samama, P. and Costa, T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends in Pharm. Sci. 14:303-307.
99. Lin, C. W. and Musacchio, J. M. (1983) The determination of dissociation constants for substance P and substance P analogues in the guinea pig ileum by pharmacological procedures. Mol. Pharmacol. 23:558-562.
100. Paton, W. D. M. and Rang, H. P (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea pig in relation to acetylcholine receptors. Proc. R. Soc. Lond. B. 163:1-44.
101. Schultz, R., Wuster, M., Krenss, H. and Hers, A. (1980) Lack of cross-tolerance on multiple opiate receptors in the vas deferens. Mol. Pharmacol. 18:395-401.
102. Schütz, W. and Freissmuth, W. B. (1992) Reverse intrinsic activity of antagonists on G proteincoupled receptors. Trends in Pharm. Sci. 13:376-380.
103. Sine, S. M. and Taylor, P. (1981) Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J. Biol. Chem. 256:6692-6699.
104. 2 and receptor differentiation: A statistical analysis of competitive antagonism (minireview). Life Sci. 25:637-654.
105. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3108.
106. Chou, T.-C. (1974) Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol. Pharmacol. 10:235-247.
107. Christopoulos, A. and Kenakin, T. (2002) G Protein-Coupled Receptor Allosterism and Complexing. Pharmacol. Rev. 54:323-374.
108. Comish-Bowden, A. and Koshland, D. E. (1975) Diagnostic uses of the Hill (Logit and Nemst) plots. J. Mol. Biol. 95:201-212.
109. Janin, J. (1973) The study of allosteric proteins. In Progress in Biophysics and Molecular Biology, J. A. V. Butler and D. Noble (eds.), pp. 77-119. New York: Pergamon Press.
110. Kenakin, T. P. (2001) Quantitation in Receptor Pharmacology. Rec. & Chan. 7:371-385.
111. Klotz, I. M. and Hunston, D. L. (1971) Properties of graphical representations of multiple classes of sites. Biochem. 10:3065-3069.
112. Koshland, D. E. (1970) The molecular basis for enzyme regulation. In The Enzymes, P. D. Boyer (ed.), chapter 7, pp. 341-396. New York: Academic Press.
113. 2A adrenergic receptor. Mol. Pharm. 53:916-925.
114. Scatchard, G. (1949) The attractions of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:660-672.
115. Whitehead, E. (1970) The regulation of enzyme activity and allosteric transition. Prog. Bioph. Mol. Biol. 21:321-397.
116. Weber, G. (1992) Protein Interactions, pp. 1-287. New York: Routledge, Chapman and Hall.
117. Wyman, J. (1948) Heme proteins. Adv. Protein Chem. 4:407-531 (especially pp. 436-443 for derivation of the Hill equation).
118. Wyman, J. and Gill, S. J. (1990) Binding and Linkage, pp. 1-308. Mill Valley, CA: University Science Books.
119. Yamamura, H. I., Enna, S. J. and Kuhar, M. J. (1985) Neurotransmitter Receptor Binding, 2nd ed. NY: Raven Press.
120. Adair, G. S. (1925) The hemoglobin system: The oxygen dissociation curve of hemoglobin. J. Biol. Chem. 63:529-545.
121. Aranyi, P. (1980) Kinetics of the hormone-receptor interaction. Competition experiments with slowly equilibrating ligands. Biochim. Biophys. Acta 628:220-227.
122. Bearer, C. F., Knapp, R. D., Kaumann, A. J., Swartz, T. L. and Bimbaumer, L. (1980) lodohydroxybenzylpindolol: Preparation, purification, localization of its iodine to the indole ring, and characterization as a partial agonist. Mol. Pharmacol. 17:328-338.
123. Burgisser, E., Hancock, A. A., Lefkowitz, R. J. and De Lean, A. (1981) Anomalous equilibrium binding properties of high-affinity racemic radioligands. Mol. Pharmacol. 19:205-216.
124. Burgisser, E., Lefkowitz, R. J. and De Lean, A. (1981) Alternative explanation for the apparent "two step" binding kinetics of high-affinity racemic antagonist radioligands. Mol. Pharmacol. 19:509-512.
125. Chang, J.-J., Jacobs, S. and Cuatrecasas, P. (1975) Quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones. Biochim. Biophys. Acta 406:294-303.
126. Colowick, S. P. and Womack, F. C. (1969) Binding of diffusible molecules by macromolecules: Rapid measurement by rate of dialysis. J. Biol. Chem 244:774-777.
127. De Lean, A. and Rodbard, D. (1979) Kinetics of cooperative binding. In Receptors: A Comprehensive Treatise, R. D. O'Brien (ed.), pp. 1443-1490. New York: Plenum Press.
128. De Lean, A., Hancock, A. A. and Lefkowitz, R. J. (1982) Validation and statistical analysis of the computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological subtypes. Mol. Pharmacol. 21:5-16.
129. De Meyts, P. Bianco, A. and Roth, J. (1976) Site-site interactions among insulin receptors. Characterization of the negative cooperativity. J. Biol. Chem. 251:1877-1888.
130. Ehlert, F. J., Roeske, W. R. and Yamamura, H. I. (1981) Mathematical analysis of the kinetics of competitive inhibition in neurotransmitter receptor binding assays. Mol. Pharmacol. 19:367-371.
131. 2+ entry blockers to cardiac sarcolemmal membrane vesicles.: Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors. J. Biol. Chem. 261:8146-8157.
132. Hill, A. V. (1910) The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J. Physiol. 40: iv-vii.
133. Hill, A. V. (1913) The combinations of haemoglobin with oxygen and with carbon monoxide. I. Biochem. J. 7:471-480.
134. Hollenberg, M. D. and Cuatrecasas, P. (1979) Distinction of receptor from non-receptor interaction in binding studies. In The Receptors: A Comprehensive Treatise, R. D. O'Brien (ed.). New York: Plenum Press.
135. Horstman, D. A., Brandon, S., Wilson, A. L., Guyer, C. A., Cragoe, Jr. E. J., and Limbird, L. E. (1990) An aspartate conserved among G-protein receptors confers allosteric regulation of a2-adrenergic receptors by sodium. J. Biol. Chem. 265(35):21590-21595.
136. Insel, P. A., Mahan, L. C., Motulsky, H. J., Stoolman, L. M. and Koachman, A. M. (1983) Timedependent decreases in binding affinity of agonists for yff-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization. J. Biol. Chem. 258:13597-13605.
137. Jacobs, S., Chang, K.-H. and Cuatrecasas, P. (1975) Estimation of hormone receptor affinity by competitive displacement of labeled ligand: Effect of concentration of receptor and of labeled ligand. Biochem. Biophys. Res. Commun. 66:687-692.
138. Klotz, I. M. (1982) Numbers of receptor sites from Scatchard graphs: Facts and fantasies. Science 217:1247-1249.
139. Koshland, D. E., Nemethy, G. and Filmer, D. (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochem. 5:365-385.
140. Langmuir, I. J. (1918) The adsorption of gases on plane surfaces of glass, mica and platinum. J. Amer. Chem. Soc. 40:1361-1372.
141. Linden, J. (1982) Calculating the dissociation constant of an unlabeled compound from the concentration required to displace radiolabel binding by 50%. J. Cycl. Nucl. Res. 8:163-172.
142. Motulsky, H. J. and Mahan, L. C. (1984) The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25:1-9.
143. Monod, J., Wyman, J. and Changeaux, J.-P. (1965) On the nature of allosteric transitions: A plausible model. J. Mol. Biol. 12:88-118.
144. Motulsky H and Christopoulos A (2003) Fitting Models to Biological Data Using Linear and Nonlinear Regression. GraphPad Software, Inc., San Diego, CA.
145. Munson, P. J. (1983) Experimental artifacts and the analysis of ligand binding data: Results of the computer simulation. J. Receptor Res. 3:249-259.
146. Munson, P. J. and Rodbard, D. (1983) Number of receptor sites from Scatchard and Klotz graphs: A constructive critique. Science 220:979-981.
147. 2-receptors in purified membranes from human platelets. Mol. Pharm. 28:475-486.
148. Pittman, R. N. and Molinoff, P. B. (1980) Interactions of agonists and antagonists with β-adrenergic receptors on intact L6 muscle cells. J. Cyclic Nucl. Res. 6:421-435.
149. Rosenthal, H. E. (1967) A graphic method for the determination and presentation of binding parameters in complex systems. Anal. Biochem. 20:525-532.
150. Taylor, S. I. (1975) Binding of hormones to receptors. An alternative explanation of nonlinear Scatchard plots. Biochem. 14:2357-2361.
151. Wyman, J. (1967) Allosteric linkage. J. Amer. Chem. Soc. 89:2202-2218.
152. Boeynaems, J. M. and Dumont, J. E. (1977) The two-step model of ligand-receptor interaction. Mol. Cell Endocrinol. 7:33-47.
153. Christopoulos, A. and Kenakin, T. (2002) G Protein-Coupled Receptor Allosterism and Complexing. Pharm. Rev. 54:323-374.
154. De Lean, A., Hancock, A. A. and Lefkowitz, R. J. (1981) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol. Pharmacol. 21:5-16.
155. De Lean, A., Munson, P. J. and Rodbard, D. (1978) Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay and physiological doseresponse curves. Am. J. Physiol. 235:E97-E102.
156. De Lean, A., Stadel, J. M. and Lefkowitz, R. J. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:7108-7117.
157. Janin, J. (1973) The study of allosteric proteins. Prog. Biophys. Mol. Biol. 27:77-119.
158. Kenakin, T. P. (2001) Quantitation in Receptor Pharmacology. Rec. & Chan. 7:371-385.
159. Kenakin, T. (2004a) Efficacy as a Vector: The Relative Prevalence and Paucity of Inverse Agonism. Mol. Pharmacol. 65:2-11.
160. Kenakin, T. (2004b) Principles: Receptor Theory in Pharmacology. Trends Pharm. Sci. 25:186-193.
161. Klotz, I. M. (1946) The application of the law of mass action to binding by proteins: Interactions with calcium. J. Am. Chem. Soc. 9:109-117.
162. Klotz, I. M. and Hunston, D. L. (1975) Protein interactions with small molecules: Relationships between stoichiometric binding constants, site binding constants, and empirical binding parameters. J. Biol. Chem. 250:3001-3009.
163. Koshland, D. E., Nemethy, G. and Filmer, D. (1966) Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochem. 5:365-385.
164. Limbird, L. E. and Motulsky, H. (1998) Receptor Identification and Characterization. In Handbook of Physiology: The Endocrine System (vol. 1). Cellular Endocrinology, chapter 4. Oxford: Oxford University Press, Inc.
165. Motulsky, H. and Christopoulos, A. (2003) GraphPad Prism. Fitting models to biological data using linear and non-linear regression. A practical guide to curve fitting. San Diego: GraphPad Software Inc. (see www.graphpad.com).
166. Munson, P. J. (1983) LIGAND: A computerized analysis of ligand binding data. Methods in Enzymol. 92:543-546.
167. Munson, P. J. and Rodbard, D. (1980) LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239.
168. Newsholme, E. A. and Start, C. (1973) Regulation in Metabolism, chapter 2. New York: John Wiley and Sons.
169. Onaran, H. O. et al. (2000) A look at receptor efficacy. From the signaling network of the cell to the intramolecular motion of the receptor. In The Pharmacology of Functional Biochemical and Recombinant Systems Handbook of Experimental Pharmacology (vol. 148), pp. 217-280. New York: Springer-Verlag.
170. Onaran, H. O. and Costa, T. (1997) Agonist efficacy and allosteric models of receptor action. Ann. NY Acad. Sci. 812:98-115.
171. Rodbard, D. (1973) A graphic method for the determination and presentation of binding parameters in complex systems. Anal. Biochem. 20:525-532.
172. 2-adrenergic receptor: Extending the ternary complex model. J. Biol. Chem. 268:4625-4636.
173. Steinhardt, J. and Reynolds, J. A. (1969) Multiple Equilibria in Proteins, chapter 2, pp. 10-33. New York: Academic Press.
174. Teipel, J. and Koshland, D. E. (1969) The significance of intermediary plateau regions in enzyme saturation curves. Biochem. 8:4656-4663.
175. Weiss, J. M., Morgan, P. H., Lutz, M. W. and Kenakin, T. P. (1996a) The cubic ternary complex receptor-occupancy model. I. Model description. J. Theor. Biol. 178:151-167.
176. Weiss, J. M., Morgan, P. H., Lutz, M. W. and Kenakin, T. P. (1996b) The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity. J, Theor. Biol. 178:169-182.
177. Weiss, J. M., Morgan, P. H., Lutz, M. W. and Kenakin, T. P. (1996c) The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy. J. Theor. Biol. 181:381-397.
178. 2- dopamine receptor of the anterior pituitary gland. Mol. Pharmacol. 26:214-227.
179. Adair, G. S. (1925) The hemoglobin system. VI. The oxygen dissociation curve of hemoglobin. J. Biol. Chem. 63:529-545.
180. Birdsall, N. J. M., Hulme, E. C. and Burgen, A. S. V. (1980). The character of the muscarinic receptors in different regions of the rat brain. Proc. Roy. Soc. Lond. B. 207:1-12.
181. Bouaboula, M., Perrachon, S., Milligan, L., Canatt, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., Maffrand, J. P., Le Fur, G. and Casellas, P. (1997) A selective inverse agonist for central canabinoid receptor inhibits mitogenactivated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem. 272:22330-22339.
182. Brady, A. E. and Limbird, L. E. (2002) G protein-coupled receptor interacting proteins: Emerging roles in localization and signal transduction. Cellular Signal. 14:297-309.
183. Burgisser, E., De Lean, A. and Lefkowitz, R. J. (1982) Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptors by guanine nucleotide. Proc. Natl. Acad. Sci. USA 79:1732-1736.
184. Bylund, D. B., Blaxall, H. S., Iversen, L. J., Caron, M. G., Lefkowitz, R. J. and Lomasney, J. W. (1992) Pharmacological characteristics of alpha2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. Mol. Pharmacol. 42:1-5.
185. Colquhoun, D. (1973) The relation between classical and cooperative models for drug action. In Drug Receptors, H. P. Rang (ed.). Baltimore: University Park, pp. 149-182.
186. De Haen, C. (1976) The non-stoichiometric floating receptor model for hormone sensitive adenylyl cyclase. J. Theoret. Biol. 58:383-400.
187. Feldman, H. A. (1972) Mathematical theory of complex ligand-binding systems at equilibrium: Some methods for parameter fitting. Anal. Biochem. 48:317-338.
188. Hancock, A. A., De Lean, A. L. and Leflcowitz, R. J. (1979) Quantitative resolution of betaadrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique. Mol. Pharmacol. 16:1-9.
189. Jacobs, S. and Cuatrecasas, P. (1976) The mobile receptor hypothesis and "cooperativity" of hormone binding: Application to insulin. Biochim. Biophys. Acta 433:482-495.
190. Karlin, A. (1967) On the application of a "plausible model" of allosteric proteins to the receptor of acetylcholine. J. Theoret. Biol. 16:306-320.
191. Katz, B. and Thesleff, S. (1957) A study of the " desensitization" produced by acetylcholine at the motor end plate. J. Physiol. 138:63-80.
192. Kent, R. S., De Lean, A. and Lefkowitz, R. J. (1980) A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17:14-23.
193. Kilpatrick, B. V. and Caron, M. G. (1983) Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors. J. Biol. Chem. 258:13528-13534.
194. Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G. and Lefkowitz, R. J. (1992) Constitutive activation of the alpha IB-adrenergic receptor by all amino acid substitutions at a single site: Evidence for a region which constrains receptor activation. J. Biol. Chem. 267:1430-1433.
195. Klotz, I. M. (1983) Ligand-receptor interactions: What we can and cannot learn from binding measurements. Trends in Pharm. Sci. 4:253-255.
196. Klotz, I. M. and Hunston, D. L. (1984) Mathematical models for ligand-receptor binding: Real sites, ghost sites. J. Biol. Chem. 259:10060-10062.
197. Lavin, T. N., Hoffman, B. B. and Lefkowitz, R. J. (1981) Determination of subtype selectivity of alpha-adrenergic ligands. Comparison of selective and non-selective radioligands. Mol. Pharmacol. 20:28-34.
198. Limbird, L. E., Gill, D. M. and Lefkowitz, R. J. (1980) Agonist-promoted coupling of the β-adrenergic receptor with the guanine nucleotide regulatory protein of the adenylate cyclase system. Proc. Natl. Acad. Sci. USA 77:775-779.
199. Michel, T. M., Hoffman, B. B., Lefkowitz, R. J. and Caron, M. G. (1981) Different sedimentation properties of agonist- and antagonist-labeled platelet alpha2-adrenergic receptors. Biochem. Biophys. Res. Comm. 100:1131-1134.
200. Neubig, R. R., Gantzos, R. D. and Thomsen, W. J. (1988) Mechanism of agonist and antagonist binding to a2-adrenergic receptors: Evidence for a precoupled receptor-guanine nucleotide protein complex. Biochemistry 27:2374-2384.
201. Smith, S. K. and Limbird, L. E. (1981) Solubilization of human platelet a-adrenergic receptors: Evidence that agonist occupancy of the receptor stabilizes receptor-effector interactions. Proc. Natl. Acad. Sci. USA 78:4026-4030.
202. Thron, CD. and Waud, D. R. (1968) The rate of action of atropine. J. Pharm. Exp. Ther. 160:91-105.
203. Bretscher, M. S. (1985) The molecules of the cell membrane. Sci. Amer. 253:100-109.
204. Hauser, H. (2000) Short-chain phospholipids as detergents. Biochim. Biophys. Acta 508:164-181.
205. Helenius, A., McCaslin, D. R., Fries, E. and Tanford, C. (1979). Properties of detergents. Methods in Enzymol. 56:734-749.
206. Helenius, A. and Simons, K. (1975) Solubilization of membranes by detergents. Biochim. Biophys. Acta 415:24-79.
207. Lichtenberg, D., Robson, R. J. and Dennis, E. A. (1983) Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim. Biophys. Acta 737:285-304.
208. Steck, T. (1974) The organization of proteins in the human red blood cell membrane. J. Cell Biol. 62:1-19.
209. Tanford, C. and Reynolds, J. A. (1976) Characterization of membrane proteins in detergent solutions. Biochim. Biophys. Acta 457:133-170.
210. Tanford, C. (1978) The hydrophobic effect and the organization of living matter. Science 200:1012-1018.
211. Tanford, C. (1973) The Hydrophobic Effect: Formation of Micelles and Biological Membranes. New York: John Wiley and Sons.
212. Ashani, Y. and Catravas, G. N. (1980) Highly reactive impurities in Triton X-100 and Brij 35: Partial characterization and removal. Anal. Biochem. 109:55-62.
213. Atha, D. H. and Ingham, K. C. (1981) Mechanism of precipitation of proteins by polyethylene glycols. J. Biol. Chem. 256:12108-12117.
214. Brown, P. J. and Schonbrunn, A. (1993) Affinity purification of a somatostatin receptor-Gprotein complex demonstrates specificity in receptor-G-protein coupling. J. Biol. Chem. 268:6668-6673.
215. Bruns, R. F., Lawson-Wendling, K. and Pugsley, T. A. (1983) A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. Anal. Biochem. 132:74-81.
216. Cann, J. R. and Hinman, N. D. (1976) Hummel-Dreyer gel chromatographic procedure as applied to ligand-mediated association. Biochem. 15:4614-4622.
217. Chang, H. W. and Bock, E. (1980) Pitfalls in the use of commercial nonionic detergents for the solubilization of integral membrane proteins: Sulfhydryl oxidizing contaminants and their elimination. Anal. Biochem. 104:112-117.
218. Colichman, E. L. (1951) Spectral study of long chain quaternary ammonium salts in bromphenol blue solutions. J. Am. Chem Soc. 73:3385-3388.
219. Edelstein, S. J. and Schachman, E. (1967) The simultaneous determination of partial specific volumes and molecular weights with microgram quantities. J. Biol. Chem. 242:306-311.
220. 125I]- iodohydroxybenzylpindolol binding to digitonin-solubilized receptors. J. Cycl. Nucl. Res. 5:407-419.
221. Gorrisen, H., Aerts, G., Ilien, B. and Laduron, P. (1981) Solubilization of muscarinic acetylcholine receptors fi-om mammalian brain: An analytical approach. Anal. Biochem. 111:33-41.
222. Green, A. A. and Hughes, W. L. (1955) Protein fi-actionation on the basis of solubility in aqueous solutions of salts and organic solvents. Methods in Enzymol. 1:67-90, especially pp. 72-78.
223. Herberg, J. T., Codina, J., Rich, K. A., Rojas, F. J. and Iyengar, R. (1984) The hepatic glucagon receptor: Solubilization, characterization and development of an affinity adsorption assay for the soluble receptor. J. Biol. Chem. 259:9285-9294.
224. Hummel, J. P. and Dreyer, W. J. (1962) Measurement of protein-binding phenomena by gel filtration. Biochim. Biophys. Acta 63:530-532.
225. Jain, M. K. and Wagner, R. C. (1980) Introduction to Biological Membranes, pp. 66-70. New York: John Wiley and Sons.
226. 4 to extracts of cucumber measured by using DEAE-cellulose filters. Proc. Natl. Acad. Sci. USA 79:1515-1519.
227. Leff, S. E. and Creese, I. (1982) Solubilization of D-2 dopamine receptors from canine caudate: Agonist-occupation stabilizes guanine nucleotide sensitive receptor complexes. Biochem. Biophys. Res. Comm. 108:1150-1157.
228. Levi, A., Cimino, M., Mercanti, D. and Calissano, P. (1974) Studies on binding of GTP to the microtubule protein. Biochim. Biophys. Acta 365:450-453.
229. Nexo, E., Hock, R. A. and Hollenberg, M. D. (1979) Lectin-agarose immobilization, a new method for detecting soluble membrane receptors. J. Biol. Chem. 254:8740-8743.
230. Oka, C, Tsujimoto, R., Kajikawa, M., Koshiba-Takeuchi, K., Ina, J., Yano, M., Tsuchiya, A., Ueta, Y., Soma, A., Kanda, H., Matsumoto, M. and Kawaichi, M. (2004) HtrAl serine protease inhibits signaling mediated by Tgfβ family proteins. Development 131:1041-1053.
231. Repaske, M. G., Nunnari, J. M. and Limbird, L. E. (1987) Purification of the a2-adrenergic receptor from porcine brain using a yohimbine-agarose affinity matrix. J. Biol. Chem. 262:12381-12386.
232. Reynolds, J. A. and Tanford, C. (1976) Determination of molecular weight of the protein moiety in protein-detergent complexes without direct knowledge of detergent binding. Proc. Natl. Acad. Sci. USA 73:4467-4470.
233. Rosenthal, K. S. and Koussale, F. (1983) Critical micelle concentration determination of nonionic detergents with Coomassie Brilliant Blue G-250. Anal. Chem. 55:1115-1117.
234. Rosevear, P., Van Alan, T., Baxter, J. and Ferguson-Miller, S. (1980) Alkyl glucoside detergents: A simpler synthesis and their effects on kinetic and physical properties of cytochrome c oxidase.
235. Ross, E. M. and Schatz, G. (1976) Cytochrome of bakers' yeast. L Isolation and properties. J. Biol. Chem. 251:1991-1996.
236. Schmidt, J. and Raftery, M. A. (1973) A simple assay for the study of solubilized acetylcholine receptors. Anal. Biochem. 52:349-354.
237. Schneider, W. J., Basu, S. K., McPhaul, M. J., Goldstein, J. L. and Brown, M. S. (1979) Solubilization of the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 76:5577-5581.
238. Smith, S. K. and Limbird, L. E. (1981) Solubilization of human platelet a-adrenergic receptors: Evidence that agonist occupancy of the receptor stabilizes receptor-effector interactions. Proc. Natl. Acad. Sci. USA 78:4026-4030.
239. Stubbs, G. W., Smith, H. G. Jr. and Litman, B. J. (1976) Alkyl glucosides as effective solubilizing agents for bovine rhodopsin: A comparison with several commonly used detergents. Biochim. Biophys. Acta 426(1):46-56.
240. 2A-Adrenergic Receptor. Biochemistry 39(4):693-700.
241. Brown, M. S., Anderson, G. W. and Goldstein, J. L. (1983) Recycling receptors: The round trip itinerary of migrant membrane proteins. Cell 32:663-667.
242. Geuze, H. J., Slot, J. W., Strous, G. J. A. M., Lodish, H. F. and Schwartz, A. L. (1983) Intracellular site of asialoglycoprotein receptor-ligand uncoupling: Double-label immunoelectron microscopy during receptor-mediated endocytosis. Cell 32:277-287.
243. Lauffenburger, D. A. and Linderman, J. (1993) Receptor/Ligand Trafficking. In Models for Binding, Trafficking and Signaling, pp. 73-132. Oxford UK: Oxford University Press.
244. Marchese, A., Chen, C, Kim, Y-M and Benovic, J. L. (2003) The ins and outs of G proteincoupled receptor trafficking. Trends Biochem. Sci. 28(7):369-376.
245. Pearse, B. M. and Robinson, M. S. (1990) Clathrin, adaptors, and sorting. Ann. Rev. Cell Biol. 6:151-171.
246. Sorkin, A. and Von Zastrow, M. (2002) Signal Transduction and Endocytosis: Close Encounters of Many Kinds. Nat. Mol. Cell. Biol. 3:600-614.
247. Turvy, D. N. and Blum, J. S. (1998) Detection of biotinylated cell surface receptors and MHC molecules in a capture ELISA: a rapid assay to measure endocytosis. M. Immunol. Meth. 212:9-18.
248. Wiley, H. S. and Cunningham, D. D. (1982) The endocytotic rate constant: A cellular parameter for quantitating receptor-mediated endocytosis. J. Biol. Chem. 257:4222-4229.
249. Wiley, H. S. (1992) Receptors: Topology, dynamics and regulation. In Fundamentals of Medical Cell Biology, Vol. 5A, "Membrane Dynamics and Signalling", pp. 113-142. JAI Press, Inc.
250. 2- Adrenergic Receptor Sequestration. J. Biol. Chem. 269(4):2790-2795.
251. 2A Receptor Occurs via the Endosome Pathway In Vitro, Mol. Pharmacol. 50:306-313.
252. 2A Receptors during Endocytosis. J. Biol. Chem. 276:8269-8277.
253. 125I-labelled human epidermal growth factor: Binding, internalization and degradation. J. Cell Biol. 71:159-171.
254. 2- Adrenergic Receptors. Mol. Pharm. 51:711-720.
255. Devreotes, P. N., Gardner, J. M. and Fambrough, D. M. (1977) Kinetics of biosynthesis of acetylcholine receptor and subsequent incorporation into plasma membrane of cultured chick skeletal muscle. Cell 10:365-373.
256. Edson, M. G. and Liggett, S. B. (1992) Subtype-selective desensitization of alpha2-adrenergic receptors. J. Biol Chem. 267:25473-25479.
257. Fehlmann, M., Carpentier, J.-L., Van Obberghen, E., Freychet, P., Thamm, P., Saunders, D., Brandenburg, D. and Orci, L. (1982) Internalized insulin receptors are recycled to the cell surface in rat hepatocytes. Proc. Natl. Acad. Sci. USA 79:5921-5925.
258. French, A. R., Sudlow, G. P., Wiley, H. S. and Lauffenburger, D. A. (1994) Postendocytotic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions. J. Biol. Chem. 269:15749-15755.
259. Goldstein, J. L., Basu, S. K., Brunschede, G. Y. and Brown, M. S. (1976) Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell 7:85-95.
260. Goldstein, J. L., Anderson, R. G. W. and Brown, M. D. (1979) Coated pits, coated vesicles, and receptor-mediated endocytosis. Nature 279:679-685.
261. 125I-epidermal growth factor in Balb/c 3T3 cells. J. Biol. Chem. 255:1239-1241.
262. Herbst, J. J., Opresko, L. K., Walsh, B. J., Lauffenburger, D. A. and Wiley, H. S. (1994) Regulation of postendocytotic trafficking of the epidermal growth factor through endosomal retention. J. Biol. Chem. 269:12365-12373.
263. Hertel, C, Coulter, S. J., Perkins, J. P. (1985) A comparison of catecholamine-induced internalization of β-adrenergic receptors and receptor-mediated endocytosis of epidermal growth factor in human astrocytoma cells. Inhibition by phenylarsine oxide. J. Biol. Chem. 260:12547-12553.
264. Hilairet, S., Belanger, C, Bertrand, J., Laperriere, A., Foord, S. M. and Bouvier, M. (2001) Agonist-promoted Internalization of a Ternary Complex between Calcitonin Receptor-like Receptor, Receptor Activity-modifying Protein 1 (RAMPl), and β-Arrestin. J. Biol. Chem. 276(45):42182-42190.
265. Insel, P., Mahan, L. C., Motulsky, H. J., Stoolman, L. M. and Koachman, A. M. (1983) Timedependent decreases in binding affinity of agonists for β-adrenergic receptors of intact S49 lymphoma cells. A mechanism of desensitization. J. Biol. Chem. 258:13597-13605.
266. Jenkinson, K. M., Southwell, B. R. and Fumess, J. B. (1999) Two affinities for a single antagonist at the neuronal NKi tachykinin receptor: evidence from quantitation of receptor endocytosis. Br. J. Pharm. 126:131-136.
267. Kadle, R., Kalter, V. G., Raizada, M. K. and Fellows, R. E. (1983) Cycloheximide causes accumulation of insulin receptors at the cell surface of cultured fibroblasts. J. Biol. Chem. 258:13116-13119.
268. 2-Adrenergic Receptor. J. Biol. Chem. 273(1):322-328.
269. Krupp, M. N., Connolly, D. T. and Lane, M. D. (1982) Synthesis, turnover and downregulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J. Biol. Chem. 257:11489-11496.
270. Krupp, M. N. and Lane, M. D. (1982) Evidence for two different pathways for the degradation of insulin and insulin receptor in the chick liver cell. J. Biol. Chem. 257:1372-1377.
271. Lloyd, C. E. and Ascoli, M. (1983) On the mechanisms involved in the regulafion of the cell surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells. J. Cell Biol. 96:521-526.
272. 1-adrenergic receptor that regulate agonist-promoted endocytosis. J. Biol. Chem. 270(12):1-6.
273. 2-adrenoceptor subtypes. Eur. J. Pharm. 244:181-185.
274. Pittman, R. N. and Molinoff, P. B. (1980) Interactions of agonists and antagonists with β-adrenergic receptors in intact L6 muscle cells. J. Cycl. Nucl. Res. 6:421-435.
275. Ronnett, G. V., Tennekoon, G., Knutson, V. P. and Lane, M. D. (1983) Kinetics of insulin receptor transit to and removal from the plasma membrane. J. Biol. Chem. 258:283-290.
276. Schwartz, A. L., Fridovich, S. E. and Lodish, H. F. (1982) Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line. J. Biol. Chem. 257:4230-4237.
277. Simantov, R. and Sachs, L. (1973) Regulation of acetylchohne receptors in relation to acetylchoHnesterase in neuroblastoma cells. Proc. Natl. Acad. Sci. USA 70:2902-2905.
278. Suavely, M. D., Ziegler, M. G. and Insel, P. A. (1985) A new approach to determine rates of receptor appearance and disappearance in vivo. Mol. Pharmacol. 27:19-26.
279. Sneddon, W. B., Syme, C. A., Bisellow, A., Magyar, C. E., Rochdi, M. D., Parent, J-L, Weinman, E. J., Abou-Samra, A. B. and Friedman, P. A. (2003) Activation-independent Parathyroid Hormone Receptor Internalization Is Regulated by NHERFl (EBP50). J. Biol. Chem. 278(44):43787-43796.
280. Staehelin, M. and Simons, P. (1982) Rapid and reversible disappearance of β-adrenergic cell surface receptors. Eur. Mol. Biol. Org. (EMBO) J. 1:187-190.
281. 3H] CGP-12177, a β-adrenergic ligand suitable for measuring cell surface receptors. J. Recept. Res. 3:35-43.
282. Staehelin, M., Simons, P., Jaeggi, K. and Wigger, N. (1983) CGP-12177. A hydrophilic padrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J. Biol. Chem. 258:3496-3502.
283. Starbuck, C. and Lauffenburger, D. A. (1992) Mathematical model for the effects of epidermal growth factor receptor trafficking dynamics in fibroblast proliferation responses. Biotechnol. Prog. 8:132-143.
284. Stoscheck, CM. and Carpenter, G. (1984) Down-regulation of epidermal growth factor receptors: Direct demonstration of receptor degradation in human fibroblasts. J. Cell. Biol. 98:1048-1053.
285. Tanowitz, M. and Von Zastrow, M. (2003) A Novel Endocytic Recycling Signal That Distinguishes the Membrane Trafficking of Naturally Occurring Opioid Receptors. J. Biol. Chem. 278(46):45978-45986.
286. Toews, M. L. and Perkins, J. P. (1984) Agonist-induced changes in β-adrenergic receptors on intact cells. J. Biol. Chem. 259:2227-2235.
287. Toews, M. L., Waldo, G. L., Harden, T. K. and Perkins, J. P. (1984) Relationship between an altered membrane form and a low affinity form of the β-adrenergic receptor occurring during catecholamine-induced desensitization: Evidence for receptor internalization. J. Biol. Chem. 259:11844-11850.
288. Vieira, A. (1998) ELISA-based assay for scatchard analysis of ligand-receptor interactions. Mol. Biotechnol. 10(3):247-250.
289. Waters, CM., Oberg, K. C., Carpenter, G. and Overholser, K. A. (1990) Rate constants for binding, dissociation, and internalization of EGF: effect of receptor occupancy and ligand concentration. Biochemistry 29(14):3563-3569.